Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product

scientific article published on February 15, 1991

Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1126/SCIENCE.1846706
P953full work available at URLhttps://syndication.highwire.org/content/doi/10.1126/science.1846706
P3181OpenCitations bibliographic resource ID2431375
P698PubMed publication ID1846706
P5875ResearchGate publication ID252121038

P50authorAndrew ChanQ57096553
P2093author name stringG. F. Vande Woude
S. A. Aaronson
J. S. Rubin
D. L. Faletto
T. E. Kmiecik
D. P. Bottaro
P2860cites workMolecular and Cellular BiologyQ3319478
Molecular cloning and expression of human hepatocyte growth factorQ24305558
Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptorsQ24339620
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Q25938983
Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific ActivityQ29618557
Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissuesQ33842687
Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factorQ35307866
A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factorQ37370202
Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinasesQ37479257
Tissue distribution of hepatopoietin-A: a heparin-binding polypeptide growth factor for hepatocytesQ37691981
Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failureQ40510836
Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxinsQ42497669
Purification and subunit structure of hepatocyte growth factor from rat plateletsQ42806247
Mechanism of met oncogene activationQ42811433
Structure of the met protein and variation of met protein kinase activity among human tumour cell linesQ43050189
The activated human met gene encodes a protein tyrosine kinaseQ43762584
Amino acid sequence of bovine protein Z: a vitamin K-dependent serine protease homologQ44257556
Molecular cloning of a new transforming gene from a chemically transformed human cell line.Q45345810
P433issue4995
P407language of work or nameEnglishQ1860
P921main subjectsignal transductionQ828130
MET proto-oncogene, receptor tyrosine kinaseQ5005897
P304page(s)802-4
P577publication date1991-02-15
P1433published inScienceQ192864
P1476titleIdentification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product
Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product
P478volume251

Reverse relations

cites work (P2860)
Q41679360"Invasive-growth" signaling by the Met/HGF receptor: the hereditary renal carcinoma connection.
Q36090934<i>In Vivo</i> Real-Time Imaging of Exogenous HGF-Triggered Cell Migration in Rat Intact Soleus Muscles
Q425363194-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) inhibits the intrahepatic spread of hepatocellular carcinoma and prolongs the life-span of tumor-bearing animals
Q4827032389Zr-DFO-AMG102 Immuno-PET to Determine Local Hepatocyte Growth Factor Protein Levels in Tumors for Enhanced Patient Selection
Q53594434A Hepatocyte Growth Factor (HGF)/receptor autocrine loop regulates constitutive self-renewal of human periodontal ligament cells but reduces sensitivity to exogenous HGF.
Q35213426A Novel Role for Bruton's Tyrosine Kinase in Hepatocyte Growth Factor-mediated Immunoregulation of Dendritic Cells
Q42365590A Novel Role of Spred2 in the Colonic Epithelial Cell Homeostasis and Inflammation.
Q57281072A Peptide Representing the Carboxyl-terminal Tail of the Met Receptor Inhibits Kinase Activity and Invasive Growth
Q104747824A Randomized, Double-Blind, Placebo- and Positive-Controlled, Three-Way Crossover Study in Healthy Participants to Investigate the Effect of Savolitinib on the QTc Interval
Q41574359A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy
Q24318269A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor
Q37329953A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis
Q40243714A genomic analysis of adult T-cell leukemia
Q36777999A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met
Q27647900A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist
Q35150412A meta analysis of pancreatic microarray datasets yields new targets as cancer genes and biomarkers
Q42821276A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation
Q40847293A novel germ line juxtamembrane Met mutation in human gastric cancer
Q40179159A novel small molecule Met inhibitor, PF2362376, exhibits biological activity against osteosarcoma.
Q33731936A point mutation in the MET oncogene abrogates metastasis without affecting transformation.
Q41533377A protein tyrosine phosphatase activity associated with the hepatocyte growth factor/scatter factor receptor
Q40119198A role for host cell exocytosis in InlB-mediated internalisation of Listeria monocytogenes.
Q40765252A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth
Q42832806A switch from p130Cas/Crk to Gab1/Crk signaling correlates with anchorage independent growth and JNK activation in cells transformed by the Met receptor oncoprotein
Q30152630A viral microRNA downregulates metastasis suppressor CD82 and induces cell invasion and angiogenesis by activating the c-Met signaling
Q40925893AIDS-related Kaposi's sarcoma. A template for the translation of molecular pathogenesis into targeted therapeutic approaches
Q36949230AXL and MET crosstalk to promote gonadotropin releasing hormone (GnRH) neuronal cell migration and survival
Q84840731Abnormality of the hepatocyte growth factor/MET pathway in pulmonary adenocarcinogenesis
Q40783581Absence of tpr-met and expression of c-met in human gastric mucosa and carcinoma.
Q55314245Acquisition of invasive phenotype in gallbladder cancer cells via mutual interaction of stromal fibroblasts and cancer cells as mediated by hepatocyte growth factor.
Q47303095Activated HGF-c-Met Axis in Head and Neck Cancer
Q35658282Activating MET kinase rearrangements in melanoma and Spitz tumours
Q36595980Activating mutations for the Met tyrosine kinase receptor in human cancer
Q42810811Activating mutations in the Met receptor overcome the requirement for autophosphorylation of tyrosines crucial for wild type signaling
Q40149614Activating transcription factor-1-mediated hepatocyte growth factor-induced down-regulation of thrombospondin-1 expression leads to thyroid cancer cell invasion
Q38324229Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor
Q40166689Activation of HGF/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cells
Q41679139Activation of Na+/H+ exchanger by hepatocyte growth factor in hepatocytes
Q38912773Activation of PAX3-MET pathways due to miR-206 loss promotes gastric cancer metastasis
Q36899460Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly
Q38507554Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA.
Q34785157Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line.
Q36326357Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice
Q37341011Adhesion proteins meet receptors: a common theme?
Q37601692Advances and future directions in the targeting of HER2-positive breast cancer: implications for the future.
Q54350584Advances on driver oncogenes of squamous cell lung cancer
Q38584644Advancing pharmacological treatment options for advanced gastric cancer
Q64070081Agonist c-Met Monoclonal Antibody Augments the Proliferation of hiPSC-derived Hepatocyte-Like Cells and Improves Cell Transplantation Therapy for Liver Failure in Mice
Q41131252Allosteric Peptide Activators of Pro-Hepatocyte Growth Factor Stimulate Met Signaling
Q71650368Alteration in growth regulation of hepatocytes in primary culture obtained from cirrhotic rat: poor response to transforming growth factor-beta 1 and interferons
Q61988145Alteration of Cardiac Progenitor Cell Potency in GRMD Dogs
Q40965305Alterative expression of the collagenase and adhesion molecules in the highly metastatic clones of human colonic cancer cell lines
Q41380865Alternatively spliced juxtamembrane domain of a tyrosine kinase receptor is a multifunctional regulatory site. Deletion alters cellular tyrosine phosphorylation pattern and facilitates binding of phosphatidylinositol-3-OH kinase to the hepatocyte gr
Q36588372Alveolar rhabdomyosarcoma - The molecular drivers of PAX3/7-FOXO1-induced tumorigenesis
Q45154742Ameliorating effect of hepatocyte growth factor on inflammatory bowel disease in a murine model
Q27690294An allosteric switch for pro-HGF/Met signaling using zymogen activator peptides
Q42088207An engineered dimeric fragment of hepatocyte growth factor is a potent c-MET agonist
Q28348554An essential role for ARF6-regulated membrane traffic in adherens junction turnover and epithelial cell migration
Q58051467Analysis of Cellular Proliferation and Survival Signaling by Using Two Ligand/Receptor Systems Modeled by Pathway Logic
Q35222611Analysis of MET genetic aberrations in patients with breast cancer at MD Anderson Phase I unit
Q34445648Analysis of MET mRNA expression in gastric cancers using RNA in situ hybridization assay: its clinical implication and comparison with immunohistochemistry and silver in situ hybridization
Q39116369Analysis of deleted variant of hepatocyte growth factor by alanine scanning mutagenesis: identification of residues essential for its biological function and generation of mutants with enhanced mitogenic activity on rat hepatocytes
Q73231784Analysis of neurotrophic effects of hepatocyte growth factor in the adult hypoglossal nerve axotomy model
Q33649756Analysis of progress and challenges for various patterns of c-MET-targeted molecular imaging: a systematic review
Q37904356Androgen receptor-mediated gene repression
Q35207666Angiogenic factors in the central nervous system
Q58850416Angiogenic factors: role in esophageal cancer, a brief review
Q34635252Anomalous nonidentity between Salmonella genotoxicants and rodent carcinogens: nongenotoxic carcinogens and genotoxic noncarcinogens
Q97525750Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance
Q39109310Anti-c-MET Nanobody - a new potential drug in multiple myeloma treatment.
Q38695456Anti-c-Met antibody bioconjugated with hollow gold nanospheres as a novel nanomaterial for targeted radiation ablation of human cervical cancer cell
Q38986019Anti-tumor activity of oridonin on SNU-5 subcutaneous xenograft model via regulation of c-Met pathway
Q35205410Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches.
Q37333311Antiserum raised against a synthetic phosphotyrosine-containing peptide selectively recognizes p185neu/erbB-2 and the epidermal growth factor receptor
Q64088535Application of Hepatocyte Growth Factor for Acute Spinal Cord Injury: The Road from Basic Studies to Human Treatment
Q39016758Application perspectives of localization microscopy in virology
Q57193553Aptamer-based search for correlates of plasma and serum water T: implications for early metabolic dysregulation and metabolic syndrome
Q42842935Are hepatocyte growth factor-like protein and macrophage stimulating protein the same protein?
Q35245109Artificial human Met agonists based on macrocycle scaffolds
Q67905743Assignment of the Hepatocyte Growth Factor (HGF) to chromosome 7q22-qter
Q50216001Association between leukocyte telomere length and angiogenic cytokines in knee osteoarthritis
Q34434985Association of the Multisubstrate Docking Protein Gab1 with the Hepatocyte Growth Factor Receptor Requires a Functional Grb2 Binding Site Involving Tyrosine 1356
Q48658526Astroglial expression of hepatocyte growth factor and hepatocyte growth factor activator in human brain tissues
Q52183618Autocrine Hepatocyte Growth Factor Provides a Local Mechanism for Promoting Axonal Growth
Q40698534Autocrine activation of the hepatocyte growth factor receptor/met tyrosine kinase induces tumor cell motility by regulating pseudopodial protrusion
Q41070912BMP-2 and OP-1 exert direct and opposite effects on renal branching morphogenesis
Q38110515Barrier Enhancing Signals in Pulmonary Edema
Q48514110Basic and clinical aspects of liver growth: Prometheus revisited. Humphry Davy Rolleston Lecture 1992.
Q41255494Basic fibroblast growth factor stimulates hepatocyte growth factor/scatter factor secretion by human mesenchymal cells
Q28506581Beta-cell-specific ablation of the hepatocyte growth factor receptor results in reduced islet size, impaired insulin secretion, and glucose intolerance
Q64071464Beyond Trophic Factors: Exploiting the Intrinsic Regenerative Properties of Adult Neurons
Q67487781Binding of scatter factor to epithelial cell membrane protein: identification of its receptor
Q37312433Biochemical basis for the functional switch that regulates hepatocyte growth factor receptor tyrosine kinase activation
Q47108041Biological roles of hepatocyte growth factor-Met signaling from genetically modified animals
Q40527929Biology of human colon cancer metastasis
Q34283653Biology of kidney cells: ontogeny-recapitulating phylogeny
Q80185223Bladder cancer cell invasion is enhanced by cross-talk with fibroblasts through hepatocyte growth factor
Q48004163Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor
Q34409663Boolean approach to signalling pathway modelling in HGF-induced keratinocyte migration
Q45038535Both Sp1 and Smad participate in mediating TGF-beta1-induced HGF receptor expression in renal epithelial cells
Q41168656Branching tubulogenesis but not scatter of madin-darby canine kidney cells requires a functional Grb2 binding site in the Met receptor tyrosine kinase
Q40398325Breast carcinoma: a collective disorder
Q40883469C-Met Proto-Oncogene Expression in Benign and Malignant Human Renal Tissues
Q58165348C-met activation is necessary but not sufficient for liver colonization by B16 murine melanoma cells
Q36743037C-terminal truncated forms of Met, the hepatocyte growth factor receptor
Q44249525CCl4-induced acute liver injury in mice is inhibited by hepatocyte growth factor overexpression but stimulated by NK2 overexpression
Q38795560Cabozantinib in genitourinary malignancies
Q42608055Canine hepatocyte growth factor: molecular cloning and characterization of the recombinant protein
Q38843388Cardiotoxin III Inhibits Hepatocyte Growth Factor-Induced Epithelial-Mesenchymal Transition and Suppresses Invasion of MDA-MB-231 Cells
Q38981340Cardiotoxin III suppresses hepatocyte growth factor-stimulated migration and invasion of MDA-MB-231 cells
Q37593693Caspases and kinases in a death grip
Q36289469Cell adhesion in invasion and metastasis
Q38125434Cell-Autonomous and Non–Cell-Autonomous Mechanisms of HGF/MET–Driven Resistance to Targeted Therapies: From Basic Research to a Clinical Perspective
Q37404891Cellular adherence elicits ligand-independent activation of the Met cell-surface receptor
Q58602771Cellular signaling and gene expression profiles evoked by a bivalent macrocyclic peptide that serves as an artificial MET receptor agonist
Q47164059Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy?
Q41471192Changes in biomarker expression in the development of prostatic adenocarcinoma
Q38288128Characterization of heparan sulfate oligosaccharides that bind to hepatocyte growth factor
Q42830729Characterization of the scatter factor/hepatocyte growth factor gene promoter. Positive and negative regulatory elements direct gene expression to mesenchymal cells
Q33273613Chemically diverse toxicants converge on Fyn and c-Cbl to disrupt precursor cell function
Q45881283Chemotaxis of skeletal muscle satellite cells
Q38320936Chicken macrophage stimulating protein is a ligand of the receptor protein-tyrosine kinase Sea.
Q36879205Chromosomal localization of rat hepatocyte growth factor (Hgf) and HGF receptor (Met) and characterization of HGF receptor cDNA.
Q42093061Clinical Development of c-MET Inhibition in Hepatocellular Carcinoma
Q37901793Clinical genomics of renal epithelial tumors
Q35051660Clinical impact of c-MET expression and genetic mutational status in colorectal cancer patients after liver resection.
Q35201636Clinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression
Q39511801Co-existence of positive MET FISH status with EGFR mutations signifies poor prognosis in lung adenocarcinoma patients
Q54566802Co-expression of hepatocyte growth factor and c-met in epithelial odontogenic tumors
Q74433027Co-expression of hepatocyte growth factor and its receptor in human prostate cancer
Q57086672Co-expression of theHGF/SF andc-met genes during early mouse embryogenesis precedes reciprocal expression in adjacent tissues during organogenesis
Q30492361Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells
Q40912185Coendocytosis of cadherin and c-Met coupled to disruption of cell-cell adhesion in MDCK cells--regulation by Rho, Rac and Rab small G proteins
Q77463268Coexpression of hepatocyte growth factor and c‐Met proto‐oncogene product in synovial sarcoma
Q73787127Coexpression of hepatocyte growth factor-Met: an early step in ovarian carcinogenesis?
Q36104060Colon cancer: prevalence, screening, gene expression and mutation, and risk factors and assessment
Q64111464Combination of cetuximab with met inhibitor in control of cetuximab-resistant oral squamous cell carcinoma
Q54601530Combined CD44, c-MET, and EGFR expression in p16-positive and p16-negative head and neck squamous cell carcinomas.
Q39044577Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancer
Q44770937Combined administration of basic fibroblast growth factor protein and the hepatocyte growth factor gene enhances the regeneration of dermis in acute incisional wounds
Q42132267Comment on "Effect of transferred NK4 gene on proliferation, migration, invasion, and apoptosis of human prostate cancer DU145 cells" by Dan Yue et al. in Asian Journal of Andrology
Q41812413Commonly deleted region on the long arm of chromosome 7 in differentiated adenocarcinoma of the stomach
Q55477950Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans
Q48199159Comparative evaluation of salivary hepatocyte growth factor in smokers and non-smokers with chronic periodontitis
Q67905746Comparison of effects of HGF and EGF on cellular calcium in rat hepatocytes
Q75421957Comparison of hepatocyte growth factor levels of epithelial ovarian cancer cyst fluids with benign ovarian cysts
Q42698660Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus
Q27320671Complete or partial reduction of the Met receptor tyrosine kinase in distinct circuits differentially impacts mouse behavior
Q53426359Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasis
Q47838353Constitutive Expression of HGF Modulates Renal Epithelial Cell Phenotype and Induces c-met and Fibronectin Expression
Q40706645Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival
Q28577402Contact inhibition of hepatocyte growth regulated by functional association of the c-Met/hepatocyte growth factor receptor and LAR protein-tyrosine phosphatase
Q37521994Contribution of human hematopoietic stem cells to liver repair.
Q71822369Contribution of primary cultures of adult human hepatocytes to the pathophysiology of hepatocellular carcinoma
Q41551941Control of invasive growth by hepatocyte growth factor (HGF) and related scatter factors
Q90287282Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer
Q44084858Cooperative actions of hepatocyte growth factor and 1,25-dihydroxyvitamin D3 in osteoblastic differentiation of human vertebral bone marrow stromal cells
Q24298462Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis
Q41507260Cooperative roles of hepatocyte growth factor and plasminogen activator in tubular morphogenesis by human microvascular endothelial cells
Q82767335Cordycepin Inhibits Renal Interstitial Myofibroblast Activation Probably by Inducing Hepatocyte Growth Factor Expression
Q44441679Correlation of P-cadherin and β-catenin expression and phosphorylation with carcinogenesis in rat tongue cancer induced with 4-nitroquinoline 1-oxide
Q41066248Correlation of hepatocyte growth factor-induced proliferation and calcium-activated potassium current in human gastric cancer cells
Q38314606Cortisol inhibits hepatocyte growth factor/scatter factor expression and induces c-met transcripts in osteoblasts
Q44321342Counteractive effects of HGF on PDGF-induced mesangial cell proliferation in a rat model of glomerulonephritis
Q40051970Coupling of Grb2 to Gab1 mediates hepatocyte growth factor-induced high intensity ERK signal required for inhibition of HepG2 hepatoma cell proliferation
Q54964139Critical role of extracellular signal-regulated kinase (ERK) phosphorylation in novel vitamin K analog-induced cell death.
Q36092910Crizotinib (PF02341066) as a ALK /MET inhibitor- Special Emphasis as a Therapeutic Drug Against Lung Cancer
Q40715731Crk synergizes with epidermal growth factor for epithelial invasion and morphogenesis and is required for the met morphogenic program
Q36407762Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing
Q27766028Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution
Q24647566Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a
Q27635335Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor.
Q36710400Current understanding of the molecular mechanisms of kidney cancer: a primer for urologists
Q35196865Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways
Q38025499Cytokines as regulators of proliferation and survival of healthy and malignant peripheral B cells
Q48402762Cytokines regulate c-Met expression in cultured astrocytes
Q41101660Cytosolic phospholipase A2 is activated by the hepatocyte growth factor receptor-kinase in Madin Darby canine kidney cells
Q47142446DISC1 Regulates the Proliferation and Migration of Mouse Neural Stem/Progenitor Cells through Pax5, Sox2, Dll1 and Neurog2.
Q34363812Decrease in the hepatic clearance of hepatocyte growth factor in carbon tetrachloride-intoxicated rats
Q39233855Decreased expression of Met during differentiation in rat lung
Q43878343Decreased microsomal triglyceride transfer protein activity contributes to initiation of alcoholic liver steatosis in rats
Q33238614Defective posttranslational processing activates the tyrosine kinase encoded by the MET proto-oncogene (hepatocyte growth factor receptor).
Q36565319Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway
Q40483903Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma
Q35159738Design and synthesis of 3,3'-biscoumarin-based c-Met inhibitors
Q35615162Design, Synthesis, and Biological Evaluation of Novel Imidazo[1,2-a]pyridine Derivatives as Potent c-Met Inhibitors
Q36135757Detection of MET and SOX2 amplification by quantitative real-time PCR in non-small cell lung carcinoma
Q53671121Detection of cancer cells in peripheral blood of stomach cancer patients using RT-PCR amplification of tumour-specific mRNAs
Q91559240Detection of colonic neoplasia in vivo using near-infrared-labeled peptide targeting cMet
Q38150768Developing biomarkers to predict benefit from HGF/MET pathway inhibitors
Q42460298Developmental and Hormonal Regulation of Hepatocyte Growth Factor Expression and Action in the Bovine Ovarian Follicle1
Q52206590Developmental biology. The scattered jigsaw
Q28286701Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase
Q72210586Different features of Ca2+ oscillations in differentiated and undifferentiated hepatocyte doublets
Q74480543Differential effect of hepatocyte growth factor and tumor growth factor-beta on early release of vascular endothelial growth factor from HepG2 cells: possible implications in post-transplant liver regeneration
Q47706538Differential expression of Met/hepatocyte growth factor receptor in subtypes of non-small cell lung cancers
Q47177700Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expression
Q46322930Differential expression of hepatocyte growth factor, transforming growth factor-alpha and transforming growth factor-beta 1 messenger RNAs in two experimental models of liver cell proliferation
Q54140216Differential expression of transforming growth factor-β and its receptors in hepatocytes and nonparenchymal cells of rat liver after CCl4 administration
Q35677691Differential mitogenic effects of single chain hepatocyte growth factor (HGF)/scatter factor and HGF/NK1 following cleavage by factor Xa.
Q38946360Differential regulation of c-Met signaling pathways for synovial cell function
Q50936610Differentiation of hUC-MSC into dopaminergic-like cells after transduction with hepatocyte growth factor
Q73174870Dimerization of Fab fragments enables ready screening of phage antibodies that affect hepatocyte growth factor/scatter factor activity on target cells
Q40962756Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase.
Q30445760Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion
Q33786959Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis
Q38770450Discovery of Potent c-MET Inhibitors with New Scaffold Having Different Quinazoline, Pyridine and Tetrahydro-Pyridothienopyrimidine Headgroups.
Q36872149Discovery of a new series of imidazo[1,2-a]pyridine compounds as selective c-Met inhibitors.
Q57283460Disruption of MET receptor tyrosine kinase, an autism risk factor, impairs developmental synaptic plasticity in the hippocampus
Q24673611Disruption of epithelial cell-matrix interactions induces apoptosis
Q44701384Dissociation of c‐Met phosphotyrosine sites in human cells in response to mouse hepatocyte growth factor but not human hepatocyte growth factor: the possible roles of different amino acids in different species
Q35961109Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor
Q38857641Dose-dependent modulation of myogenesis by HGF: implications for c-Met expression and downstream signalling pathways.
Q35619182Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy
Q43649368Down-regulation of MET, the receptor for hepatocyte growth factor.
Q28214978Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development
Q92139717Downregulation of long non-coding RNA TUG1 suppresses tumor growth by promoting ubiquitination of MET in diffuse large B-cell lymphoma
Q39716806Dynamics of adherence junctions during early stages of epithelial-mesenchymal transition: possible mechanisms of tube and alveolus formation in ontogeny
Q34720575Dynamics of cell interactions and communications during melanoma development
Q53232399Dysregulation of HGF/c-Met signal pathway and their targeting drugs in lung cancer
Q34584046Dysregulation of Met receptor tyrosine kinase activity in invasive tumors
Q38951627EGF potentiation of VEGF production is cell density dependent in H292 EGFR wild type NSCLC cell line
Q37355527ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non–Small Cell Lung Cancer
Q54571801Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells.
Q64282122Effect of ethanol on lipid metabolism
Q72785129Effect of hepatocyte growth factor on the expression of E- and P-cadherin in gastric carcinoma cell lines
Q41626187Effect of scatter factor and hepatocyte growth factor on motility and morphology of MDCK cells
Q43684978Effects of MACC1 siRNA on biological behaviors of HeLa
Q45888077Effects of Recombinant Adenovirus Hepatocyte Growth Factor Gene on Myocardial Remodeling in Spontaneously Hypertensive Rats
Q55479613Effects of hepatocyte growth factor (HGF) on human glioma cells in vitro: HGF acts as a motility factor in glioma cells.
Q40848614Effects of hepatocyte growth factor on differentiation and cMET receptor expression in the promyelocytic HL60 cell line
Q42125760Effects of hepatocyte growth factor on glutathione synthesis, growth, and apoptosis is cell density-dependent
Q41674298Effects of hepatocyte growth factor on viability and biotransformation functions of hepatocytes in gel entrapped and monolayer culture
Q35237704Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells
Q42459326Effects of protein kinase inhibitors on the mitogenic activity of human hepatocyte growth factor on rat hepatocytes in primary culture
Q33718726Efficacy of c-Met inhibitor for advanced prostate cancer
Q34434226Efficient Cellular Transformation by the Met Oncoprotein Requires a Functional Grb2 Binding Site and Correlates with Phosphorylation of the Grb2-associated Proteins, Cbl and Gab1
Q38801405Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells
Q46313791Elevated hepatocyte growth factor levels at the beginning of high-flux hemodialysis are due to heparin administration
Q33744636Embryonic renal epithelia: induction, nephrogenesis, and cell differentiation
Q37723147Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern?
Q38506084Emerging kinase inhibitors of the treatment of gastric cancer
Q41052630Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo
Q33963349Enhanced transformation by a plasma membrane-associated met oncoprotein: activation of a phosphoinositide 3'-kinase-dependent autocrine loop involving hyaluronic acid and CD44.
Q52172861Enhancement by hepatocyte growth factor of bone and cartilage formation during embryonic mouse mandibular development in vitro
Q74302476Enhancement of intestinal adaptation by hepatocyte growth factor
Q38174770Epidermal growth factor receptor mutations in lung adenocarcinoma
Q36090650Epidermal growth factor receptor plays a significant role in hepatocyte growth factor mediated biological responses in mammary epithelial cells
Q74586947Epidermal growth factor- and hepatocyte growth factor-receptor activity in serum-free cultures of human hepatocytes
Q34616966Epigallocatechin-3-gallate inhibits paracrine and autocrine hepatocyte growth factor/scatter factor-induced tumor cell migration and invasion
Q39439183Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
Q35427474Epithelial differentiation of metanephric mesenchymal cells after stimulation with hepatocyte growth factor or embryonic spinal cord
Q27860487Epithelial-mesenchymal transitions in tumour progression
Q38885876Erk2 but not Erk1 regulates crosstalk between Met and EGFR in squamous cell carcinoma cell lines
Q40647943Erythropoietin receptors associate with a ubiquitin ligase, p33RUL, and require its activity for erythropoietin-induced proliferation
Q53381863Establishment and characterisation of human papillomavirus type 16 DNA immortalised human tonsillar epithelial cell lines
Q73003047Evaluation of the tyrosine kinase domain of the Met proto-oncogene in sporadic ovarian carcinomas*
Q28297450Evidence for autocrine basis of transformation in NIH-3T3 cells transfected with met/HGF receptor gene
Q37574028Evidence for the identity of human scatter factor and human hepatocyte growth factor
Q41730896Evolution of Plasminogen‐Related Growth Factors (HGF/SF and HGF1/MSP)
Q73890634Existence of two nonlinear elimination mechanisms for hepatocyte growth factor in rats
Q40752904Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis
Q34127138Experimental approaches for the treatment of malignant gliomas
Q57360231Exploring the chemical space of the lysine-binding pocket of the first kringle domain of hepatocyte growth factor/scatter factor (HGF/SF) yields a new class of inhibitors of HGF/SF-MET binding
Q43825933Expression and action of hepatocyte growth factor in bovine endometrial stromal and epithelial cells in vitro*
Q42483953Expression and action of hepatocyte growth factor in human and bovine normal ovarian surface epithelium and ovarian cancer
Q36382913Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain
Q38847534Expression array analysis of the hepatocyte growth factor invasive program
Q73012367Expression of HGF mRNA in human rejecting kidney as evidenced by in situ hybridization
Q46331084Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue
Q48076736Expression of HGF/SF, HGF1/MSP, and c-met suggests new functions during early chick development
Q35782214Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors.
Q41931002Expression of a human hepatocyte growth factor/scatter factor cDNA in MDCK epithelial cells influences cell morphology, motility, and anchorage-independent growth
Q30940447Expression of c-Met in developing rat hippocampus: evidence for HGF as a neurotrophic factor for calbindin D-expressing neurons
Q38472256Expression of c-met is a strong independent prognostic factor in breast carcinoma
Q55284672Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance.
Q52199057Expression of cytokeratin 14 in ameloblast-lineage cells of the developing tooth of rat, both in vivo and in vitro
Q41628116Expression of c‐met proto‐oncogene in COS cells induces the signal transducing high‐affinity receptor for hepatocyte growth factor
Q28368255Expression of heparin-binding epidermal growth factor-like growth factor in the hepatocytes of fibrotic rat liver during hepatocarcinogenesis
Q38512195Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma
Q28571293Expression of hepatocyte growth factor and c-met genes during hepatic differentiation and liver development in the rat
Q41014013Expression of hepatocyte growth factor and its receptor c-met in human leukemia-lymphoma cell lines
Q72879597Expression of hepatocyte growth factor mRNA, and c-met mRNA (hepatocyte growth factor receptor) in human liver tumours
Q40848894Expression of hepatocyte growth factor receptor (c-met) mRNA in primary cultures of human hepatocytes
Q77333937Expression of hepatocyte growth factor/scatter factor and c-Met in human dental papilla and fibroblasts from dental papilla
Q52195048Expression of hepatocyte growth factor/scatter factor and its receptor, MET, suggests roles in human embryonic organogenesis
Q40878257Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) on prostate cancer cell lines
Q73977662Expression of the HGF/SF Receptor, c-met, and Its Ligand in Human Colorectal Cancers
Q38472554Expression of the Hepatocyte Growth Factor and c-met in Normal Thyroid, Non-neoplastic, and Neoplastic Nodules
Q42389733Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression
Q72719873Expression of the c-met protooncogene in human hepatocellular carcinoma
Q35975907Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts
Q24555664Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor
Q36268138Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells
Q38941681FOXC2 promotes colorectal cancer metastasis by directly targeting MET.
Q40413613Factors controlling growth, motility, and morphogenesis of normal and malignant epithelial cells.
Q35687676Familial Renal Cancer: Molecular Genetics and Surgical Management
Q36713219Fibroblast Growth Factors in Normal and Malignant Melanocytes
Q36924414Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met
Q79371211Fine-needle aspiration cytology of papillary renal cell carcinoma: the association with concomitant secondary malignancies
Q49619487First-in-human phase I dose escalation study of MK-8033 in patients with advanced solid tumors
Q33593910Fluorescence in situ hybridization in surgical pathology: principles and applications
Q31026830Focal enhancement of expression of c-Met/hepatocyte growth factor receptor in the myocardium in human myocardial infarction
Q38081379Foretinib (XL880): c-MET Inhibitor with Activity in Papillary Renal Cell Cancer
Q36287691Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer
Q71830006Frequent expression of genes for receptor tyrosine kinases and their ligands in human pancreatic cancer cells
Q36745364From Tpr-Met to Met, tumorigenesis and tubes.
Q35146586Function and regulation of melanoma-stromal fibroblast interactions: when seeds meet soil
Q42987814Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli
Q34267718Functional map and domain structure of MET, the product of the c- met protooncogene and receptor for hepatocyte growth factor/scatter factor
Q40561060Gallbladder cancer treatment using adenovirus expressing the HGF/NK4 gene in a peritoneal implantation model.
Q40763145Ganglioside GD1a inhibits HGF-induced motility and scattering of cancer cells through suppression of tyrosine phosphorylation of c-Met
Q39545863Ganglioside GD1a negatively regulates hepatocyte growth factor expression through caveolin-1 at the transcriptional level in murine osteosarcoma cells
Q28571998Gender difference in the Oatp1-mediated tubular reabsorption of estradiol 17beta-D-glucuronide in rats
Q71458873Gene expressions of c-met and hepatocyte growth factor in chronic liver disease and hepatocellular carcinoma
Q38806819Gene of the month: HGF.
Q54354044Genentech to salvage anti-MET antibody with subgroup analysis
Q41659418Genes involved in oncogenesis
Q34178906Genes that regulate metastasis and angiogenesis
Q47833619Genetic alterations in human epithelial thyroid tumours
Q34177743Genetic and epigenetic changes in stomach cancer
Q37409032Genetics and genomics of melanoma
Q45126118Genomic mapping of intracisternal A-particle proviral elements
Q33737789Germline Met Mutations in Mice Reveal Mutation- and Background-Associated Differences in Tumor Profiles
Q45978082Grade II astrocytomas are subgrouped by chromosome aberrations.
Q40042989Grb2-associated binder-1 plays a central role in the hepatocyte growth factor enhancement of hepatoma growth inhibition by K vitamin analog compound 5.
Q74453641Growth Factors
Q38112030Growth Factors and Cytokines in Acute Lung Injury
Q37774602Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.
Q28593533Growth factor-induced tyrosine phosphorylation of Hrs, a novel 115-kilodalton protein with a structurally conserved putative zinc finger domain
Q35228793Growth factors and cell proliferation
Q37592665Growth factors and corneal epithelial wound healing
Q37045217Growth factors and oncogenes as targets in melanoma: lost in translation?
Q37253563Growth factors and tyrosine protein kinases in normal and malignant melanocytes
Q36468089Growth factors in liver development, regeneration and carcinogenesis
Q40603473Growth factors. A scattering of factors
Q98195589HGF and IL-10 expressing ALB::GFP reporter cells generated from iPSCs show robust anti-fibrotic property in acute fibrotic liver model
Q34983851HGF and MET mutations in primary and secondary lymphedema
Q40486672HGF and liver regeneration
Q24324832HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death
Q43876212HGF regulates VEGF expression via the c-Met receptor downstream pathways, PI3K/Akt, MAPK and STAT3, in CT26 murine cells
Q50977859HGF-Met Pathway in Regeneration and Drug Discovery
Q35078530HGF-independent potentiation of EGFR action by c-Met
Q39720254HGF-promoted motility in primary human melanocytes depends on CD44v6 regulated via NF-kappa B, Egr-1, and C/EBP-beta
Q51795590HGF/Met Signaling Is a Key Player in Malignant Mesothelioma Carcinogenesis
Q74213837HGF/SF Is Present in Normal Adult Skeletal Muscle and Is Capable of Activating Satellite Cells
Q41730938HGF/SF in Angiogenesis
Q28142539HGF/SF in mammary epithelial growth and morphogenesis: in vitro and in vivo models
Q36027374HGF/SF-Met signaling in tumor progression
Q28202466HGF/SF-met signaling in the control of branching morphogenesis and invasion
Q60920855HGF/c-MET Signaling in Melanocytes and Melanoma
Q39214964HGF–MET Cascade, a Key Target for Inhibiting Cancer Metastasis: The Impact of NK4 Discovery on Cancer Biology and Therapeutics
Q36685708Has MET met its match?
Q42550713Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling
Q36236835Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2.
Q59355524Hepatocellular Carcinoma: Causes, Mechanism of Progression and Biomarkers
Q35227361Hepatocellular carcinoma: Recent progress
Q41641693Hepatocyte Growth Factor (HGF) as a Tissue Organizer for Organogenesis and Regeneration
Q36405721Hepatocyte Growth Factor Effects on Mesenchymal Stem Cells Derived from Human Arteries: A Novel Strategy to Accelerate Vascular Ulcer Wound Healing.
Q41007751Hepatocyte Growth Factor Enables Enhanced Integrin–Cytoskeleton Linkage by Affecting Integrin Expression in Subconfluent Epithelial Cells
Q39557490Hepatocyte Growth Factor Inhibits Anoikis of Pancreatic Carcinoma Cells Through Phosphatidylinositol 3-Kinase Pathway
Q50977853Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling
Q47999769Hepatocyte Growth Factor Protects Renal Epithelial Cells from Apoptotic Cell Death
Q77403442Hepatocyte Growth Factor and the Kidney: It Is Not Just for the Liver
Q30168070Hepatocyte Growth Factor/scatter factor-induces phosphorylation of cortactin in A431 cells in a Src kinase-independent manner
Q30048844Hepatocyte growth factor
Q43212568Hepatocyte growth factor
Q52188248Hepatocyte growth factor (HGF) acts as a mesenchyme-derived morphogenic factor during fetal lung development
Q38671668Hepatocyte growth factor (HGF) and hemodialysis: physiopathology and clinical implications
Q68053555Hepatocyte growth factor (HGF) mediates the sustained formation of 1,2-diacylglycerol via phosphatidylcholine-phospholipase C in cultured rat hepatocytes
Q43708445Hepatocyte growth factor (HGF) protects c-met-expressing Burkitt's lymphoma cell lines from apoptotic death induced by DNA damaging agents
Q48528548Hepatocyte growth factor (HGF/SF) in Alzheimer's disease
Q48046833Hepatocyte growth factor (HGF/SF) is a muscle-derived survival factor for a subpopulation of embryonic motoneurons
Q33879210Hepatocyte growth factor (HGF/SF) is expressed in human epithelial cells during embryonic development; studies by in situ hybridisation and northern blot analysis.
Q28581772Hepatocyte growth factor activates phosphoinositide 3-kinase C2 beta in renal brush-border plasma membranes
Q40987305Hepatocyte growth factor and Madin-Darby canine kidney cells: in vitro models of epithelial cell movement and morphogenesis
Q38377273Hepatocyte growth factor and Met in drug discovery
Q35798481Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis
Q35796063Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma
Q35618611Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells.
Q58134190Hepatocyte growth factor and met: Molecular dialogue for tissue organization and repair
Q51368364Hepatocyte growth factor and omega-3–enriched feeds have a synergistic effect on mucosal mass in an animal model of inflammatory bowel disease
Q41893732Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth
Q30851343Hepatocyte growth factor enhances death receptor-induced apoptosis by up-regulating DR5
Q73564746Hepatocyte growth factor enhances intestinal mucosal cell function and mass in vivo
Q78415738Hepatocyte growth factor expression in dextran sodium sulfate-induced colitis in rats
Q44406096Hepatocyte growth factor gene therapy of liver cirrhosis in rats
Q47778187Hepatocyte growth factor gene transfer to alveolar septa for effective suppression of lung fibrosis.
Q41660621Hepatocyte growth factor has potent anti-proliferative activity in various tumor cell lines
Q74418608Hepatocyte growth factor in cerebrospinal fluid in neurologic disease
Q44146987Hepatocyte growth factor in gingival crevicular fluid and the distribution of hepatocyte growth factor-activator in gingival tissue from adult periodontitis
Q72316322Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression
Q41957264Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy
Q44158059Hepatocyte growth factor incorporated into herpes simplex virus vector accelerates facial nerve regeneration after crush injury.
Q45176759Hepatocyte growth factor induces an endothelin-mediated decline in glomerular filtration rate
Q34972866Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail
Q36234949Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors.
Q28270220Hepatocyte growth factor induces proliferation and morphogenesis in nonparenchymal epithelial liver cells
Q40398127Hepatocyte growth factor induces redistribution of p21(CIP1) and p27(KIP1) through ERK-dependent p16(INK4a) up-regulation, leading to cell cycle arrest at G1 in HepG2 hepatoma cells
Q58199731Hepatocyte growth factor induction of collagenase 3 production in human osteoarthritic cartilage: Involvement of the stress-activated protein kinase/c-Jun N-terminal kinase pathway and a sensitive p38 mitogen-activated protein kinase inhibitor cascad
Q33778883Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells
Q28216726Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFkappa B
Q51639051Hepatocyte growth factor inhibits the formation of the basement membrane of alveolar epithelial cells in vitro
Q37430185Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro.
Q28366555Hepatocyte growth factor is a mitogen for olfactory ensheathing cells
Q41596252Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
Q38088776Hepatocyte growth factor is an attractive target for the treatment of pulmonary fibrosis
Q52124110Hepatocyte growth factor is essential for migration of myogenic cells and promotes their proliferation during the early periods of tongue morphogenesis in mouse embryos
Q42496320Hepatocyte growth factor is upregulated by low-density lipoproteins and inhibits endothelin-1 release
Q91658835Hepatocyte growth factor is upregulated in ischemic retina and contributes to retinal vascular leakage and neovascularization
Q36134413Hepatocyte growth factor levels in bone marrow plasma of patients with leukaemia and its gene expression in leukaemic blast cells
Q53562460Hepatocyte growth factor levels in gingival crevicular fluid in health, disease, and after treatment
Q48060473Hepatocyte growth factor mRNA in human liver cirrhosis as evidenced by in situ hybridization
Q36188460Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models.
Q41049567Hepatocyte growth factor plays a dual role in regulating skeletal muscle satellite cell proliferation and differentiation
Q92135271Hepatocyte growth factor plays a particular role in progression of overall cardiac damage in experimental pulmonary hypertension
Q35229384Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice
Q43919088Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine
Q73674188Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3-kinase
Q43755855Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis
Q43409496Hepatocyte growth factor protects retinal ganglion cells by increasing neuronal survival and axonal regeneration in vitro and in vivo.
Q40544580Hepatocyte growth factor protects small airway epithelial cells from apoptosis induced by tumor necrosis factor-alpha or oxidative stress
Q40098619Hepatocyte growth factor receptor c-MET is associated with FAS and when activated enhances drug-induced apoptosis in pediatric B acute lymphoblastic leukemia with TEL-AML1 translocation
Q40726384Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection.
Q48828270Hepatocyte growth factor reduces the infarct volume after transient focal cerebral ischemia in rats.
Q73627004Hepatocyte growth factor region specifically activates mucin synthesis in rat stomach
Q36627067Hepatocyte growth factor stimulates neutrophil degranulation but not respiratory burst
Q51719677Hepatocyte growth factor stimulates proliferation of respiratory epithelial cells during postpneumonectomy compensatory lung growth in mice
Q47789900Hepatocyte growth factor stimulates the growth and activates mitogen-activated protein kinase in human hepatoma cells
Q42817345Hepatocyte growth factor stimulates the invasion of gallbladder carcinoma cell lines in vitro
Q37825664Hepatocyte growth factor twenty years on: Much more than a growth factor
Q74212928Hepatocyte growth factor up-regulates SGLT1 and GLUT5 gene expression after massive small bowel resection
Q40876225Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes
Q44822548Hepatocyte growth factor--a new marker for prognosis in acute coronary syndrome
Q40931230Hepatocyte growth factor--pleiotropic cytokine produced by human leukemia cells
Q37735624Hepatocyte growth factor/MET in cancer progression and biomarker discovery
Q36840751Hepatocyte growth factor/Met gene transfer in cardiac stem cells--potential for cardiac repair
Q46659007Hepatocyte growth factor/c-met promotes proliferation, suppresses apoptosis, and improves matrix metabolism in rabbit nucleus pulposus cells in vitro
Q41870321Hepatocyte growth factor/c-met signaling in regulating urokinase plasminogen activator in human stomach cancer: A potential therapeutic target for human stomach cancer
Q35070805Hepatocyte growth factor/scatter factor and MET are involved in arterial repair and atherogenesis
Q41055453Hepatocyte growth factor/scatter factor and the placenta
Q43746983Hepatocyte growth factor/scatter factor blocks the mitochondrial pathway of apoptosis signaling in breast cancer cells
Q41972231Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases
Q33331790Hepatocyte growth factor/scatter factor enhances the thrombopoietin mRNA expression in rat hepatocytes and cirrhotic rat livers
Q71606366Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer
Q35833646Hepatocyte growth factor/scatter factor expression in human mammary epithelium
Q35575126Hepatocyte growth factor/scatter factor in development, inflammation and carcinogenesis: its expression and role in oral tissues
Q73072251Hepatocyte growth factor/scatter factor in the eye
Q36236279Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells
Q31963959Hepatocyte growth factor/scatter factor induces not only scattering but also cohort migration of human colorectal-adenocarcinoma cells
Q40753421Hepatocyte growth factor/scatter factor inhibits UVB-induced apoptosis of human keratinocytes but not of keratinocyte-derived cell lines via the phosphatidylinositol 3-kinase/AKT pathway
Q43819365Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons
Q36134982Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients
Q33863966Hepatocyte growth factor/scatter factor-induced intracellular signalling
Q83409298Hepatocyte growth factor: Molecular biomarker and player in cardioprotection and cardiovascular regeneration
Q36804493Hepatocyte growth factor: a regenerative drug for acute hepatitis and liver cirrhosis
Q28217543Hepatocyte growth factor: from diagnosis to clinical applications
Q28277720Hepatocyte nuclear factor-4 is responsible for the liver-specific expression of the gene coding for hepatocyte growth factor-like protein
Q71342319Hepatocyte proliferation and serum hepatocyte growth factor levels in patients with alcoholic hepatitis
Q72853763Hepatocyte-specific expression of the mouse hepatocyte growth factor-like protein
Q46227413Hgf/c-met expression and functional analysis during zebrafish embryogenesis
Q33727656High concentrations of HGF inhibit skeletal muscle satellite cell proliferation in vitro by inducing expression of myostatin: a possible mechanism for reestablishing satellite cell quiescence in vivo.
Q40782695High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2.
Q77596983High levels of hepatocyte growth factor/scatter factor in diffuse-type bronchioloalveolar cell carcinoma
Q34277757Histone Deacetylases Activate Hepatocyte Growth Factor Signaling by Repressing MicroRNA-449 in Hepatocellular Carcinoma Cells
Q37849841How are proliferation and differentiation of melanocytes regulated?
Q28273985Human Hrs, a tyrosine kinase substrate in growth factor-stimulated cells: cDNA cloning and mapping of the gene to chromosome 17
Q22010783Human JIK, a novel member of the STE20 kinase family that inhibits JNK and is negatively regulated by epidermal growth factor
Q42679094Human hepatocyte growth factor inhibits early neointima formation in rabbit abdominal aortae following ultrasound-guided balloon injury
Q34091020Human hepatocyte growth factor promotes functional recovery in primates after spinal cord injury
Q41592353Human lung cancer cell line producing hepatocyte growth factor/scatter factor
Q41718628Human umbilical cord mesenchymal stem cells infected with adenovirus expressing HGF promote regeneration of damaged neuron cells in a Parkinson's disease model
Q92242780Humanized Anti-hepatocyte Growth Factor Monoclonal Antibody (YYB-101) Inhibits Ovarian Cancer Progression
Q24651389Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity
Q46870070Identification and partial characterization of two classes of receptors for human hepatocyte growth factor on adult rat hepatocytes in primary culture
Q38332144Identification of a Competitive HGF Antagonist Encoded by an Alternative Transcript
Q41431686Identification of a cell-type-specific transcriptional repressor in the promoter region of the mouse hepatocyte growth factor gene
Q41656206Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor
Q40866279Identification of a novel splicing product of the RON receptor tyrosine kinase in human colorectal carcinoma cells
Q41589743Identification of a novel tyrosine kinase receptor-like molecule in neuroblastomas
Q42140971Identification of mannose receptor as receptor for hepatocyte growth factor β-chain: novel ligand-receptor pathway for enhancing macrophage phagocytosis
Q42003695Identifying the Appropriate FISH Criteria for Defining MET Copy Number-Driven Lung Adenocarcinoma through Oncogene Overlap Analysis
Q92423962ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors
Q78780257Immunoexpression of hepatocyte growth factor and c-Met receptor in the eutopic endometrium predicts the activity of ectopic endometrium
Q40471164Immunogold labeling of oncogenic and tumor related proteins
Q34745711Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis
Q42526215Immunohistochemical detection of hepatocyte growth factor, transforming growth factor-beta and their receptors in epithelial odontogenic tumors
Q55286947Immunohistochemical detection of hepatocyte growth factor/scatter factor in human cancerous and inflammatory lesions of various organs.
Q39432024Immunohistochemical expressions of fatty acid synthase and phosphorylated c-Met in thyroid carcinomas of follicular origin
Q28592355Immunohistochemical localization of hepatocyte growth factor activator (HGFA) in developing mouse liver tissues. Heterogeneous distribution of HGFA protein
Q54991781Immunohistochemical localization of hepatocyte growth factor protein in pancreas islet A-cells of man and rats
Q37939411Immunomodulatory properties of mesenchymal stem cells: cytokines and factors.
Q40961095Impact of MET inhibition on small-cell lung cancer cells showing aberrant activation of the hepatocyte growth factor/MET pathway.
Q36415423Importance of the brain Angiotensin system in Parkinson's disease
Q35821392Improvement of Sepsis by Hepatocyte Growth Factor, an Anti-Inflammatory Regulator: Emerging Insights and Therapeutic Potential
Q92589040In Utero Amniotic Fluid Stem Cell Therapy Protects Against Myelomeningocele via Spinal Cord Coverage and Hepatocyte Growth Factor Secretion
Q40006800In vitro and in vivo bioactivity of recombinant canine hepatocyte growth factor
Q35832669In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas.
Q35325715In-depth proteomic analysis of six types of exudative pleural effusions for nonsmall cell lung cancer biomarker discovery.
Q38976616Increase of MET gene copy number confers resistance to a monovalent MET antibody and establishes drug dependence
Q36184256Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer
Q41180196Increased PTHRP production by a tyrosine kinase oncogene, Tpr-Met: role of the Ras signaling pathway
Q74065208Increased Serum Concentrations of Human Hepatocyte Growth Factor in Proliferative Diabetic Retinopathy
Q73402061Increased c-Met tyrosine kinase expression in segmental renal dysplasia
Q83340733Increased circulating hepatocyte growth factor (HGF): a marker of epithelial ovarian cancer and an indicator of poor prognosis
Q43710391Increased hepatocyte growth factor in serum in acute graft-versus-host disease
Q30768542Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease
Q38342749Increased secretion of hepatocyte growth factor by eutopic endometrial stromal cells in women with endometriosis
Q37419975Inducible HGF-secreting Human Umbilical Cord Blood-derived MSCs Produced via TALEN-mediated Genome Editing Promoted Angiogenesis
Q36896058Induction of Apoptosis by Hepatocyte Growth Factor/Scatter Factor and Its Augmentation by Phorbol Esters in Meth A Cells
Q35746620Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma
Q46628502Induction of cyclin mRNA and cyclin-associated histone H1 kinase during liver regeneration
Q41076941Induction of hepatocyte growth factor/scatter factor by interferon-γ in human leukemia cells
Q41079007Induction of human microvascular endothelial tubular morphogenesis by human keratinocytes: Involvement of transforming growth factor-α
Q73626597Influence of Luminal Hepatocyte Growth Factor on Small Intestine Mucosain Vivo
Q43815854Influence of hepatocyte growth factor, epidermal growth factor, and mycophenolic acid on endothelin‐1 synthesis in human endothelial cells
Q73135954Influence of the host microenvironment on the clonal selection of human colon carcinoma cells during primary tumor growth and metastasis
Q35851661Inherited forms of renal cell carcinoma
Q44737495Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy
Q71645459Inhibition of motility and invasion of human lung cancer cells by invasion inhibiting factor 2
Q67737256Inhibition of tumor implantation at sites of trauma by Arg-Gly-Asp containing proteins and peptides
Q40221705Inhibitory effect of c-Met mutants on the formation of branching tubules by a porcine aortic endothelial cell line
Q53443154Interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis
Q77373979Interactions between scatter factors and their receptors: hints for therapeutic applications
Q40738685Intermediate cells in normal and malignant prostate epithelium express c-MET: implications for prostate cancer invasion
Q40771829International Standards for hepatocyte growth factor/scatter factor: initial assessment of candidate materials and their evaluation by multicentre collaborative study
Q24295561Interplay between scatter factor receptors and B plexins controls invasive growth
Q68056301Intracellular calcium as a second messenger for human hepatocyte growth factor in hepatocytes
Q44611913Intramyocardial transfer of hepatocyte growth factor as an adjunct to CABG: phase I clinical study
Q28253680Invasive growth: a MET-driven genetic programme for cancer and stem cells
Q34584035Invasive growth: from development to metastasis
Q35277738Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation
Q34786196Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase
Q48056993Involvement of Livertine, a hepatocyte growth factor family member, in neural morphogenesis
Q38613138Involvement of Membrane Blebbing in Immunological Disorders and Cancer
Q34737879Involvement of an SHP-2-Rho small G protein pathway in hepatocyte growth factor/scatter factor-induced cell scattering.
Q24296442Involvement of hepatocyte growth factor in branching morphogenesis of murine salivary gland
Q40957403Involvement of oxidative stress in tumor cytotoxic activity of hepatocyte growth factor/scatter factor
Q54017063Involvement of the hepatocyte growth factor/scatter factor receptor c-met and of Bcl-xL in the resistance of oropharyngeal cancer to ionizing radiation
Q42634662Isolation and characterization of a novel liver-specific gene, hepassocin, upregulated during liver regeneration
Q88613156Isoquercitrin, ingredients in Tetrastigma hemsleyanum Diels et Gilg, inhibits hepatocyte growth factor/scatter factor-induced tumor cell migration and invasion
Q39565607KAI1 inhibits HGF-induced invasion of pancreatic cancer by sphingosine kinase activity
Q34171969Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium
Q39227712Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9
Q43093134Knockdown of stromal interaction molecule 1 attenuates hepatocyte growth factor-induced endothelial progenitor cell proliferation
Q52318134Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy.
Q41351099L-ascorbic acid 2-phosphate and fibroblast growth factor-2 treatment maintains differentiation potential in bone marrow-derived mesenchymal stem cells through expression of hepatocyte growth factor
Q52536919Liver gene disruptions: winners by KO?
Q37052713Liver regeneration and tumor stimulation--a review of cytokine and angiogenic factors.
Q28569831Localization and functional role of hepatocyte growth factor (HGF) and its receptor c-met in the rat developing cerebral cortex
Q74454051Localization of Hepatocyte Growth Factor and Its Receptor met in Endocrine Cells and Related Tumors of the Gut and Pancreas: An Immunohistochemical Study
Q51320328Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway
Q33700482Loss of c-Met disrupts gene expression program required for G2/M progression during liver regeneration in mice
Q36232389Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene
Q34461690Loss of glutathione peroxidase 3 expression is correlated with epigenetic mechanisms in endometrial adenocarcinoma
Q40937368Loss of the exon encoding the juxtamembrane domain is essential for the oncogenic activation of TPR-MET.
Q30157439MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis
Q36949256MET Expression and Amplification in Patients with Localized Gastric Cancer
Q39327047MET Increases the Sensitivity of Gefitinib-Resistant Cells to SN-38, an Active Metabolite of Irinotecan, by Up-Regulating the Topoisomerase I Activity
Q90227747MET Inhibitors in Small Cell Lung Cancer: From the Bench to the Bedside
Q33688421MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit
Q37485001MET abnormalities in patients with genitourinary malignancies and outcomes with c-MET inhibitors
Q55491411MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis.
Q37232416MET as a target for treatment of chest tumors
Q26781054MET deregulation in breast cancer
Q42819406MET expression in melanoma correlates with a lymphangiogenic phenotype
Q38389999MET genetic lesions in non-small-cell lung cancer: pharmacological and clinical implications
Q38390016MET inhibition in lung cancer
Q38956316MET overexpression and gene amplification in NSCLC: a clinical perspective.
Q37427292MET pathway as a therapeutic target
Q38167461MET receptor tyrosine kinase as an autism genetic risk factor
Q28253238MET receptor tyrosine kinase controls dendritic complexity, spine morphogenesis, and glutamatergic synapse maturation in the hippocampus
Q37811895MET signalling: principles and functions in development, organ regeneration and cancer
Q36265149MET-EGFR dimerization in lung adenocarcinoma is dependent on EGFR mtations and altered by MET kinase inhibition
Q60909538MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk
Q36520263MET/HGF Signaling Pathway in Ovarian Carcinoma: Clinical Implications and Future Direction
Q37735662MET4 expression predicts poor prognosis of gastric cancers with Helicobacter pylori infection
Q27008925MET: A Critical Player in Tumorigenesis and Therapeutic Target
Q39121333MET: roles in epithelial-mesenchymal transition and cancer stemness
Q37463551MITF mutations associated with pigment deficiency syndromes and melanoma have different effects on protein function
Q38281572MSP: an emerging player in metabolic syndrome
Q38116308MSP–RON signalling in cancer: pathogenesis and therapeutic potential
Q38720357Macrophage stimulating protein is a novel neurotrophic factor
Q43892652Macrophage-stimulating protein is a neurotrophic factor for embryonic chicken hypoglossal motoneurons
Q55003815Mammary fibroblast-derived hepatocyte growth factor stimulates growth and morphogenesis of mouse mammary tumor cells in primary culture.
Q37629000Matriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancer.
Q53580017Maxillary carcinosarcoma: Identification of a novel MET mutation in both carcinomatous and sarcomatous components through next generation sequencing.
Q34085432Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression
Q42522963Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production
Q26772969Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer
Q73631523Mechanisms regulating c-met overexpression in liver-metastatic B16-LS9 melanoma cells
Q41006411Mediators, cytokines, and growth factors in liver-lung interactions
Q38683133Medullary Thyroid Cancer: Clinical Characteristics and New Insights into Therapeutic Strategies Targeting Tyrosine Kinases
Q35038893Medullary Thyroid Carcinoma: Molecular Signaling Pathways and Emerging Therapies
Q36727744Membrane Biochemistry and Chemical Hepatocarcinogenesis
Q34710895Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts
Q39409196Met Kinase-dependent Loss of the E3 Ligase Cbl in Gastric Cancer
Q34440764Met identification on human platelets: role of hepatocyte growth factor in the modulation of platelet activation
Q34236194Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis
Q36987592Met provides essential signals for liver regeneration
Q28140219Met receptor tyrosine kinase: enhanced signaling through adapter proteins
Q28235183Met, metastasis, motility and more
Q30446159Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells
Q39153274Met-induced membrane blebbing leads to amoeboid cell motility and invasion
Q36621835Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers
Q24600512Metabolism of Kidney Cancer: From the Lab to Clinical Practice
Q37111703Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1
Q36278121MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET.
Q37735617MicroRNA-181b-5p, ETS1, and the c-Met pathway exacerbate the prognosis of pancreatic ductal adenocarcinoma after radiation therapy
Q34211970MicroRNA-34a Inhibits the Proliferation and Metastasis of Osteosarcoma Cells Both In Vitro and In Vivo
Q41245385Microtubule dynamic turnover is suppressed during polarization and stimulated in hepatocyte growth factor scattered Madin-Darby canine kidney epithelial cells
Q42833899Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells
Q61441303Mitotic activity of rat muscle satellite cells in response to serum stimulation: relation with cellular metabolism
Q27867714Mode of receptor binding and activation by plasminogen‐related growth factors1
Q40043365Modulating effects of the extracellular sequence of the human insulinlike growth factor I receptor on its transforming and tumorigenic potential.
Q81392233Modulation of E-cadherin by hepatocyte growth factor induces aggressiveness of gastric carcinoma
Q50423780Molecular Regulation of Sprouting Angiogenesis
Q57037017Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma
Q34099128Molecular characteristics of eight gastric cancer cell lines established in Japan
Q36414504Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay
Q36704207Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP)
Q35691515Molecular imaging of c-Met tyrosine kinase activity.
Q53483428Molecular mechanism of stomach carcinogenesis
Q33365218Molecular mechanisms of activating c-MET in KSHV+ primary effusion lymphoma
Q40895993Molecular requirements for the effect of neuregulin on cell spreading, motility and colony organization
Q47640113Molecular specification of facial branchial motor neurons in vertebrates
Q42151322Molecular therapy targeting Sonic hedgehog and hepatocyte growth factor signaling in a mouse model of medulloblastoma
Q45896729Monitoring of TNFR1, IL-2Rα, HGF, CCL8, IL-8 and IL-12p70 following HSCT and their role as GVHD biomarkers in paediatric patients.
Q53789447Monoclonal Antibodies against the MET/HGF Receptor and Its Ligand: Multitask Tools with Applications from Basic Research to Therapy
Q36921877Morphogenetic Effects of Neuregulin (Neu Differentiation Factor) in Cultured Epithelial Cells
Q36236949Motogenic and morphogenic activity of epithelial receptor tyrosine kinases
Q35027903Motor neuron trophic factors: Therapeutic use in ALS?
Q26821959Multikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinib
Q40461761Multiple biological responses are induced by glycosylation-deficient hepatocyte growth factor
Q91762173Multipotent Neurotrophic Effects of Hepatocyte Growth Factor in Spinal Cord Injury
Q42810535Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists
Q35081210Mutant p53 cooperates with knockdown of endogenous wild-type p53 to disrupt tubulogenesis in Madin-Darby canine kidney cells
Q30537354Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion
Q42799761Mutation of Cys672 allows recombinant expression of activatible macrophage-stimulating protein
Q34482678Mutation of juxtamembrane tyrosine residue 1001 suppresses loss-of-function mutations of the met receptor in epithelial cells.
Q47752292Mutational analysis of the TrkA gene in prostate cancer
Q40761395Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF.
Q34784692Myocardial transfection with naked DNA plasmid encoding hepatocyte growth factor prevents the progression of heart failure in dogs
Q39399346Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy
Q38322471Nanobody-based cancer therapy of solid tumors
Q30442626Nanobody: the "magic bullet" for molecular imaging?
Q36067773Necrotic cell-derived high mobility group box 1 attracts antigen-presenting cells but inhibits hepatocyte growth factor-mediated tropism of mesenchymal stem cells for apoptotic cell death.
Q28573753Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro
Q24629814Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models
Q37853198New targeted therapies for gastric cancer
Q38591976Non-HER2 signaling pathways activated in resistance to anti-HER2 therapy in breast cancer.
Q43201388Non-autocrine, constitutive activation of Met in human anaplastic thyroid carcinoma cells in culture
Q30484106Noncoding mutations of HGF are associated with nonsyndromic hearing loss, DFNB39.
Q27015094Normal morphogenesis of epithelial tissues and progression of epithelial tumors
Q41193408Novel Madin Darby canine kidney cell clones exhibit unique phenotypes in response to morphogens
Q92882785Novel Peptide CM 7 Targeted c-Met with Antitumor Activity
Q35902144Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells
Q24291392Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow
Q35079472Novel role for endogenous hepatocyte growth factor in the pathogenesis of intracranial aneurysms.
Q38132622Novel therapies for the management of short bowel syndrome in children
Q35553298Obstructive nephropathy and renal fibrosis: The role of bone morphogenic protein-7 and hepatocyte growth factor
Q33781303Omental adipose tissue is a more suitable source of canine Mesenchymal stem cells
Q40698212Oncogenes and anti-oncogenes in human epithelial thyroid tumors
Q30194476Oncogenes, protein tyrosine kinases, and signal transduction
Q35154868Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase
Q33969327Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway
Q35753572Ontogeny of hepatocyte growth factor (HGF) and its receptor (c-met) in human placenta: reduced HGF expression in intrauterine growth restriction
Q34882260Origin of renal cell carcinomas.
Q38030130Overcoming resistance to EGFR inhibitor in head and neck cancer: A review of the literature
Q35742089Overexpression of MACC1 and the association with hepatocyte growth factor/c-Met in epithelial ovarian cancer
Q37663252Overexpression of MET is a new predictive marker for anti-EGFR therapy in metastatic colorectal cancer with wild-type KRAS.
Q36497156Overexpression of NK2 inhibits liver regeneration after partial hepatectomy in mice
Q72282167Overexpression of c-met protooncogene product and raised Ki67 index in hepatocellular carcinomas with respect to benign liver conditions
Q77303734Overexpression of scatter factor and its receptor (c‐met) in oral squamous cell carcinoma
Q48075337Overexpression of the c-MET/HGF receptor in human thyroid carcinomas derived from the follicular epithelium.
Q72998611Overexpression of the c-Met/HGF receptor and its prognostic significance in uterine cervix carcinomas
Q58617725Overexpression-mediated activation of MET in the Golgi promotes HER3/ERBB3 phosphorylation
Q54514590O‐Linked Triazolotriazines: Potent and Selective c‐Met Inhibitors
Q36292961Paracrine effects of hepatocyte growth factor/scatter factor on non-small-cell lung carcinoma cell lines
Q38485203Paracrine growth regulation of human colon carcinoma organ-specific metastasis
Q35219328Pathobiology and chemoprevention of bladder cancer
Q37633128Pax3 modulates expression of the c-Met receptor during limb muscle development
Q92705174Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma
Q92364940Phage display screening of therapeutic peptide for cancer targeting and therapy
Q92625988Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma
Q33918113Phase I ficlatuzumab monotherapy or with erlotinib for refractory advanced solid tumours and multiple myeloma
Q38257674Phosphotyrosine profiling of NSCLC cells in response to EGF and HGF reveals network specific mediators of invasion.
Q50985118Physiological Signaling and Structure of the HGF Receptor MET.
Q40487497Pigmentation and Proliferation of Human Melanocytes and the Effects of Melanocyte‐Stimulating Hormone and Ultraviolet B Lighta
Q89965744Placental Protein 13 (Galectin-13) Polarizes Neutrophils Toward an Immune Regulatory Phenotype
Q28307227Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor
Q28262774Plasma biomarkers discriminate clinical forms of multiple sclerosis
Q37457584Plasma dynamic monitoring of soluble c-Met level for EGFR-TKI treatment in advanced non-small cell lung cancer
Q42285931Plasma hepatocyte growth factor and biliprotein levels and outcome in fulminant hepatic failure
Q41341072Plexin: A novel neuronal cell surface molecule that mediates cell adhesion via a homophilic binding mechanism in the presence of calcium ions
Q39116344Possible involvement of p21/waf1 in the growth inhibition of HepG2 cells induced by hepatocyte growth factor
Q35943226Pre-Osteoblasts Stimulate Migration of Breast Cancer Cells via the HGF/MET Pathway
Q47302253Preclinical Evaluation of a Novel c-Met Inhibitor in a Gastric Cancer Xenograft Model Using Small Animal PET
Q38782345Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma.
Q39373209Preclinical evaluation of biomarkers for response monitoring to the MET inhibitor BAY-853474.
Q41152341Primary human fibroblasts induce diverse tumor invasiveness: involvement of HGF as an important paracrine factor
Q28071589Profile of tivantinib and its potential in the treatment of hepatocellular carcinoma: the evidence to date
Q44718464Prognostic Value of Hepatocyte Growth Factor Receptor Expression in Patients with Perihilar Cholangiocarcinoma
Q33748638Prognostic value of MET gene copy number and protein expression in patients with surgically resected non-small cell lung cancer: a meta-analysis of published literatures
Q36375213Prognostic value of c-Met expression in oral squamous cell carcinoma
Q38522829Progress and prospects of endothelial progenitor cell therapy in coronary stent implantation
Q38007133Progress in cancer therapy targeting c-Met signaling pathway
Q28081311Progress in corneal wound healing
Q78148740Progression-linked overexpression of c-Met in prostatic intraepithelial neoplasia and latent as well as clinical prostate cancers
Q35195484Proliferation of Hepatic Oval Cells via Cyclooxygenase-2 and Extracellular Matrix Protein Signaling during Liver Regeneration Following 2-AAF/Partial Hepatectomy in Rats
Q38502350Promise and challenges on the horizon of MET-targeted cancer therapeutics
Q40851985Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-Met
Q28278555Prostate cancer and the met hepatocyte growth factor receptor
Q39210179Prostate cancer stem‐like cells/cancer‐initiating cells have an autocrine system of hepatocyte growth factor
Q40867771Protein tyrosine kinase growth factor receptors and their ligands in development, differentiation, and cancer
Q77386429Proteolytic Cleavage and Activation of pro-Macrophage-Stimulating Protein and Upregulation of its Receptor in Tissue Injury
Q72864099Proteolytic processing of the hepatocyte growth factor/scatter factor receptor by furin
Q35832227Proto-oncogene and growth factor/receptor expression in the establishment of primary human non-small cell lung carcinoma cell lines.
Q34364284Putative miRNAs for the diagnosis of dyslexia, dyspraxia, and specific language impairment.
Q40675521Quantifying cell scattering: the blob algorithm revisited
Q24594529RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP
Q39131172Radiofrequency ablation suppresses distant tumour growth in a novel rat model of multifocal hepatocellular carcinoma.
Q34293078Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102
Q36676217Rapid induction of mRNAs for liver regeneration factor and insulin-like growth factor binding protein-1 in primary cultures of rat hepatocytes by hepatocyte growth factor and epidermal growth factor
Q40171635Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage
Q37233640Reactive oxygen species regulate urokinase plasminogen activator expression and cell invasion via mitogen-activated protein kinase pathways after treatment with hepatocyte growth factor in stomach cancer cells
Q40456921Rearrangements of TRK proto-oncogene in papillary thyroid carcinomas.
Q28645740Recent Advances in the Genetics of Vocal Learning
Q38703338Recent Progress in Therapeutic Strategies for Ischemic Stroke
Q28083779Receptor tyrosine kinase signaling: regulating neural crest development one phosphate at a time
Q38193038Receptor tyrosine kinases: legacy of the first two decades
Q35229808Reciprocal activating crosstalk between c-Met and caveolin 1 promotes invasive phenotype in hepatocellular carcinoma
Q39511886Recombinant immunotoxin anti-c-Met/PE38KDEL inhibits proliferation and promotes apoptosis of gastric cancer cells
Q42796653Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis
Q34025084Regulated expansion of human pancreatic beta-cells
Q51335207Regulation of HGF and c-MET Interaction in Normal Ovary and Ovarian Cancer
Q40771902Regulation of Ras and Rho small G proteins by SHP‐2
Q42234289Regulation of Signal Transduction and Role of Platelets in Liver Regeneration
Q34121488Regulation of Skp2 levels by the Pim-1 protein kinase
Q42947434Regulation of cytokine signaling by B cell antigen receptor and CD40-controlled expression of heparan sulfate proteoglycans
Q41034938Regulation of lnvasive Potential of Human Prostate Cancer Cell Lines by Hepatocyte Growth Factor
Q41438276Regulation of scatter factor production via a soluble inducing factor
Q40021756Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells
Q61857463Regulation of spreading and growth of colon cancer cells by hepatocyte growth factor
Q40977563Regulation of the c-met proto-oncogene promoter by p53.
Q93738081Reply
Q40755904Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis
Q39976834Requirement of kinesin-mediated membrane transport of WAVE2 along microtubules for lamellipodia formation promoted by hepatocyte growth factor
Q36189390Resistance to targeted cancer drugs through hepatocyte growth factor signaling
Q46713687Retinal Pigment Epithelial Cells Secrete and Respond to Hepatocyte Growth Factor
Q33829589Rho-like GTPases: their role in epithelial cell-cell adhesion and invasion
Q73534478Rho-like GTPases: their role in epithelial cell-cell adhesion and invasion
Q46920527Rho/ROCK-dependent pseudopodial protrusion and cellular blebbing are regulated by p38 MAPK in tumour cells exhibiting autocrine c-Met activation
Q35200337Role of HGF/MET axis in resistance of lung cancer to contemporary management
Q74287365Role of HGF/c-met system in invasion and metastasis of oral squamous cell carcinoma cells in vitro and its clinical significance
Q38331058Role of NF-kappaB signaling in hepatocyte growth factor/scatter factor-mediated cell protection
Q38424220Role of c-mesenchymal-epithelial transition pathway in gastric cancer.
Q38134309Role of cMET in the development and progression of colorectal cancer
Q77571474Role of hepatocyte growth factor and its receptor c-met in multiple myeloma
Q27027957Role of mesenchymal-epithelial transition amplification in resistance to anti-epidermal growth factor receptor agents
Q38167258Role of met axis in head and neck cancer
Q35426283Role of scatter factor in the pathogenesis of AIDS-related Kaposi sarcoma.
Q28581402Roles of hepatocyte growth factor and its receptor in gastric mucosa. A cell biological and molecular biological study
Q36235129Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros
Q33923757Roles of hepatocyte growth factor/scatter factor and transforming growth factor-beta1 in mammary gland ductal morphogenesis
Q71695471Roles of prostaglandin production and mitogen-activated protein kinase activation in hepatocyte growth factor-mediated rat hepatocyte proliferation
Q28346588Ron-mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses
Q43559869SB365, Pulsatilla saponin D, targets c-Met and exerts antiangiogenic and antitumor activities
Q92630759SMYD3: An Oncogenic Driver Targeting Epigenetic Regulation and Signaling Pathways
Q44512484SNPs of bovine HGF gene and their association with growth traits in Nanyang cattle
Q50026427Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer
Q36133180Safety of Onartuzumab in Patients with Solid Tumors: Experience to Date from the Onartuzumab Clinical Trial Program
Q40951683Scatter factor and angiogenesis
Q24564783Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor
Q40560399Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction
Q35782032Scatter factor binds to thrombospondin and other extracellular matrix components
Q33324581Scatter factor from human embryonic lung fibroblasts is probably identical to hepatocyte growth factor
Q36141804Scatter factor induces blood vessel formation in vivo
Q41062796Scatter factor induces segregation of multinuclear cells into several discrete motile domains
Q41071769Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells
Q35782449Scatter factor protein levels in human breast cancers: clinicopathological and biological correlations
Q33778706Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas
Q42770153Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development
Q24683896Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
Q28504542Scatter factor/hepatocyte growth factor is essential for liver development
Q34277050Scatter factor/hepatocyte growth factor stimulation of glioblastoma cell cycle progression through G(1) is c-Myc dependent and independent of p27 suppression, Cdk2 activation, or E2F1-dependent transcription
Q34318015Searching for the hereditary causes of renal-cell carcinoma
Q39385631Sensitivity of Selected Human Tumor Models to PF-04217903, a Novel Selective c-Met Kinase Inhibitor
Q36236069Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland
Q52898206Serum hepatocyte growth factor as a possible indicator of arteriosclerosis
Q46036524Serum hepatocyte growth factor is increased in Hashimoto's thyroiditis whether or not it is associated with nodular goiter as compared with healthy non-goitrous individuals.
Q50944558Serum hepatocyte growth factor/scatter factor levels in small cell lung cancer patients
Q73418817Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma
Q35228909Signal Transduction by the Colony-Stimulating Factor-1 Receptor; Comparison to Other Receptor Tyrosine Kinases
Q45318112Signaling by MET
Q32134611Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma.
Q40806188Signaling pathways leading to transcription and translation cooperatively regulate the transient increase in expression of c-Fos protein
Q35051630Significance of c-MET overexpression in cytotoxic anticancer drug-resistant small-cell lung cancer cells
Q39472980Silencing of c-Met by RNA interference inhibits the survival, proliferation, and invasion of nasopharyngeal carcinoma cells.
Q37437415Simm530, a novel and highly selective c-Met inhibitor, blocks c-Met-stimulated signaling and neoplastic activities
Q73977486Simultaneous or Delayed Administration of Hepatocyte Growth Factor Equally Represses the Fibrotic Changes in Murine Lung Injury Induced by Bleomycin
Q55474924Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells.
Q64063166Single Chromosome Aneuploidy Induces Genome-Wide Perturbation of Nuclear Organization and Gene Expression
Q33816457Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery
Q52866578Small Molecules Revealed in a Screen Targeting Epithelial Scattering Are Inhibitors of Microtubule Polymerization.
Q37968256Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer
Q43826670Soluble c-Met expression in the peritoneal fluid and serum of patients with different stages of endometriosis
Q44601949Soluble c-Met protein as a susceptible biomarker for gastric cancer risk: A nested case-control study within the Korean Multicenter Cancer Cohort
Q73586595Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas
Q38359975Sp1 and Sp3 transcription factors synergistically regulate HGF receptor gene expression in kidney
Q40533285Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells
Q31538849Src homology 2-containing inositol 5-phosphatase 1 binds to the multifunctional docking site of c-Met and potentiates hepatocyte growth factor-induced branching tubulogenesis.
Q42797749Src phosphorylates Grb2-associated binder 1 upon hepatocyte growth factor stimulation
Q58726253Status of Agents Targeting the HGF/c-Met Axis in Lung Cancer
Q40855544Stimulation of hepatocyte growth factor production by ascorbic acid and its stable 2-glucoside
Q72615840Stimulation of prostaglandin production by hepatocyte growth factor in human gastric carcinoma cells
Q74218439Stimulatory Effects of Hepatocyte Growth Factor on Hemopoiesis of SCF/c‐kit System‐Deficient Mice
Q38922319Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.
Q39641555Strong neurogenesis, angiogenesis, synaptogenesis, and antifibrosis of hepatocyte growth factor in rats brain after transient middle cerebral artery occlusion
Q40541604Structural and functional basis of the serine protease-like hepatocyte growth factor beta-chain in Met binding and signaling
Q42831711Structural and functional characterization of the mouse c-met proto-oncogene (hepatocyte growth factor receptor) promoter
Q34572895Structural basis of hepatocyte growth factor/scatter factor and MET signalling
Q28274665Structure and function of hepatocyte growth factor
Q33938013Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding
Q40672745Suppression of HGF receptor gene expression by oxidative stress is mediated through the interplay between Sp1 and Egr-1.
Q33943764Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase
Q31971336Syndecan-1 expression inhibits myoblast differentiation through a basic fibroblast growth factor-dependent mechanism.
Q52125404Syndecan-3 and Syndecan-4 Specifically Mark Skeletal Muscle Satellite Cells and Are Implicated in Satellite Cell Maintenance and Muscle Regeneration
Q28074119Synergistic Anticancer Effect of Tocotrienol Combined with Chemotherapeutic Agents or Dietary Components: A Review
Q52576043Synergistic antitumor effects of cMet inhibitor in combination with anti-VEGF in colorectal cancer patient-derived xenograft models
Q40694894Synergistic effect of focal adhesion kinase overexpression and hepatocyte growth factor stimulation on cell transformation
Q34062598Synergistic role of sprouty2 inactivation and c-Met up-regulation in mouse and human hepatocarcinogenesis
Q53978706Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation
Q59129187Synthesis of novel 6,7-dimethoxy-4-anilinoquinolines as potent c-Met inhibitors
Q64056071Synthesis, Evaluation, and Mechanism Study of New Tepotinib Derivatives as Antiproliferative Agents
Q35525917TAK-701, a humanized monoclonal antibody to hepatocyte growth factor, reverses gefitinib resistance induced by tumor-derived HGF in non-small cell lung cancer with an EGFR mutation
Q92830528Targeted Therapies in Non-small-Cell Lung Cancer
Q40386229Targeted delivery of HGF to the skeletal muscle improves glucose homeostasis in diet-induced obese mice.
Q38127728Targeted therapy for NSCLC with driver mutations
Q38053680Targeting Angiogenesis as a Promising Modality for the Treatment of Prostate Cancer
Q36406993Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma
Q37463739Targeting HSP90 for cancer therapy
Q37978193Targeting MET in cancer: rationale and progress
Q38116707Targeting MET: why, where and how?
Q64253749Targeting Tyrosine kinases in Renal Cell Carcinoma: "New Bullets against Old Guys"
Q38856729Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges
Q38585471Targeting c-Met in Cancer by MicroRNAs: Potential Therapeutic Applications in Hepatocellular Carcinoma
Q35153149Targeting c-Met receptor overcomes TRAIL-resistance in brain tumors
Q36567735Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling.
Q36234151Targeting of the SF/HGF receptor to the basolateral domain of polarized epithelial cells
Q36766188Targeting the HGF-cMET Axis in Hepatocellular Carcinoma
Q37013777Targeting the HGF/Met signaling pathway in cancer therapy
Q36142604Targeting the HGF/Met signalling pathway in cancer.
Q36093497Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma
Q24606259Targeting the Hepatocyte Growth Factor–cMET Axis in Cancer Therapy
Q37792116Targeting the MET oncogene in cancer and metastases.
Q38297235Targeting the MET pathway for potential treatment of NSCLC.
Q37331862Targeting the Met signaling pathway in renal cancer.
Q30449821Targets and delivery methods for therapeutic angiogenesis in peripheral artery disease
Q42143312The Antitumor Effect of C-terminus of Hsp70-Interacting Protein via Degradation of c-Met in Small Cell Lung Cancer
Q35982925The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer.
Q36536993The Blocking of c-Met Signaling Induces Apoptosis through the Increase of p53 Protein in Lung Cancer
Q39290479The Expression Pattern of Von Hippel-Lindau Tumor Suppressor Protein, MET Proto-oncogene, and TFE3 Transcription Factor Oncoprotein in Renal Cell Carcinoma in Upper Egypt
Q74388657The Functions of HGF/SF and its Receptor, the c‐Met Tyrosine Kinase, in Mammalian Development
Q34724977The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.
Q46358843The HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non-Small Cell Lung Cancer
Q41079348The HMC-1 Human Mast Cell Line Expresses the Hepatocyte Growth Factor Receptor c-met
Q34141913The Hepatocyte Growth Factor Receptor: Structure, Function and Pharmacological Targeting in Cancer
Q54117888The Impact of the Epithelial-Mesenchymal Transition Regulator Hepatocyte Growth Factor Receptor/Met on Skin Immunity by Modulating Langerhans Cell Migration
Q59020063The Janus factor
Q34173500The Met oncogene and basal-like breast cancer: another culprit to watch out for?
Q41563732The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells
Q35078950The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response-Biological and Clinical Aspects
Q44504094The N-terminal domain of hepatocyte growth factor inhibits the angiogenic behavior of endothelial cells independently from binding to the c-met receptor
Q43940479The PI3K-Akt mediates oncogenic Met-induced centrosome amplification and chromosome instability
Q50977867The Pathogenetic Role of the HGF/c-Met System in Papillary Carcinoma of the Thyroid
Q58566840The Role of PI3K in Met Driven Cancer: A Recap
Q55405777The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis.
Q33855107The Ron/STK receptor tyrosine kinase is essential for peri-implantation development in the mouse
Q40744469The SH2-containing inositol 5-phosphatase (SHIP)-1 is implicated in the control of cell-cell junction and induces dissociation and dispersion of MDCK cells
Q45286070The SH2-domian-containing inositol 5-phosphatase (SHIP)-2 binds to c-Met directly via tyrosine residue 1356 and involves hepatocyte growth factor (HGF)-induced lamellipodium formation, cell scattering and cell spreading
Q74326065The Upstream Regulatory Regions of the Hepatocyte Growth Factor Gene Promoter Are Essential for Its Expression in Transgenic Mice
Q55065289The absolute bioavailability investigation of LS177 in rats using ultra-performance liquid chromatography-tandem mass spectrometry.
Q35224818The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis.
Q42679093The autism susceptibility gene met regulates zebrafish cerebellar development and facial motor neuron migration
Q34224909The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer
Q28081415The clinical and functional significance of c-Met in breast cancer: a review
Q37201797The clinical implications of the genetics of renal cell carcinoma
Q73816403The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase
Q24609298The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine
Q48271358The expression of mRNAs for hepatocyte growth factor/scatter factor, its receptor c-met, and one of its activators tissue-type plasminogen activator show a systematic relationship in the developing and adult cerebral cortex and hippocampus
Q53426264The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice
Q40556528The function of neurotrophic factor receptors expressed by the developing adductor motor pool in vivo.
Q35190150The genetics of malignant melanoma: lessons from mouse and man.
Q39736711The hepatocyte growth factor isoform NK2 activates motogenesis and survival but not proliferation due to lack of Akt activation
Q58165507The hepatocyte growth factor receptor (MET): An unconventional transducer of mitogenic and motogenic signals
Q41155456The hepatocyte growth factor receptor kinase-mediated phosphorylation of lipocortin-1 transduces the proliferating signal of the hepatocyte growth factor
Q33922881The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation.
Q35563524The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis
Q24679595The human gene encoding acetylcholinesterase is located on the long arm of chromosome 7
Q32053890The human hepatocyte growth factor receptor gene: complete structural organization and promoter characterization
Q24564727The ltk gene encodes a novel receptor-type protein tyrosine kinase
Q42048597The mitogenic activity of hepatocyte growth factor on rat hepatocytes is dependent upon endogenous transforming growth factor-alpha
Q36395707The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing
Q41098848The molecular pathogenesis of hepatocellular carcinoma.
Q28072910The more the messier: centrosome amplification as a novel biomarker for personalized treatment of colorectal cancers
Q33969029The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair
Q36843122The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering.
Q36735738The mutationally activated Met receptor mediates motility and metastasis
Q34699035The neurobiology of autism
Q49113731The p185erbB2 protein is localized on cell organelles involved in cell motility
Q34658478The pathogenesis of diabetic retinopathy: old concepts and new questions
Q33769429The potential roles of hepatocyte growth factor (HGF)-MET pathway inhibitors in cancer treatment
Q48429605The presence of hepatocyte growth factor in the developing rat
Q35994188The presence of scatter factor in patients with metastatic spread to the pleura
Q28360983The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat
Q24310383The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade
Q30454058The protooncogene c-sea encodes a transmembrane protein-tyrosine kinase related to the Met/hepatocyte growth factor/scatter factor receptor
Q37950469The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials
Q40877521The role of cell adhesion molecules in cancer invasion and metastasis
Q42453664The role of hepatocyte growth factor (HGF) at progressive stages of metanephric development
Q28363959The role of hepatocyte growth factor and its receptor c-met in interactions between lymphocytes and stromal cells in secondary human lymphoid organs
Q89017919The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models
Q27748909The solution structure of the N-terminal domain of hepatocyte growth factor reveals a potential heparin-binding site
Q47810132The synergistic therapeutic effect of hepatocyte growth factor and granulocyte colony-stimulating factor on pulmonary hypertension in rats
Q38798344The tumour-stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients
Q38313083The tyrosine kinase receptor c-met, its cognate ligand HGF and the tyrosine kinase receptor trasducers STAT3, PI3K and RHO in thyroid nodules associated with Hashimoto's thyroiditis: an immunohistochemical characterization
Q30450983The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro
Q28280668The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase
Q36840731Therapeutic Strategies for Bone Metastases and Their Clinical Sequelae in Prostate Cancer
Q33696791Therapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcoma
Q36915616Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis
Q47986761Three receptor genes for plasminogen related growth factors in the genome of the puffer fish Fugu rubripes
Q47822132Thyroid cancer: predisposing conditions, growth factors, signal transduction and oncogenes
Q48354828Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway
Q38957671Toward operative in vivo fluorescence imaging of the c-Met proto-oncogene for personalization of therapy in ovarian cancer.
Q40894504Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1.
Q73038986Transcriptional regulation of the hepatocyte growth factor gene by the nuclear receptors chicken ovalbumin upstream promoter transcription factor and estrogen receptor
Q36065558Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene
Q42049096Transforming Growth Factor α Levels in Liver and Blood Correlate Better than Hepatocyte Growth Factor with Hepatocyte Proliferation during Liver Regeneration
Q41129457Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells
Q36961089Transforming growth factor-β1 selectively inhibits hepatocyte growth factor expression via a micro-RNA-199–dependent posttranscriptional mechanism
Q37356573Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors
Q36036437Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer
Q46847345Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy.
Q39240834Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials
Q37059865Tumor Biomarkers in Spindle Cell Variant Squamous Cell Carcinoma of the Head and Neck
Q38811204Tumor Specific Recruitment and Reprogramming of Mesenchymal Stem Cells in Tumorigenesis
Q74128408Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma
Q40765166Tumor cell growth inhibition and extracellular signal-regulated kinase (ERK) phosphorylation by novel K vitamins 1 1Edited by M. Yaniv
Q33324580Tumor cytotoxic factor/hepatocyte growth factor from human fibroblasts: cloning of its cDNA, purification and characterization of recombinant protein
Q80332141Tumor hypoxia and expression of c-met in cervical cancer
Q42800257Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src.
Q36705281Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor
Q41007034Tyrosine Phosphorylation of Focal Adhesion Kinase Stimulated by Hepatocyte Growth Factor Leads to Mitogen-activated Protein Kinase Activation
Q36333766Tyrosine kinases and their interactions with signalling proteins
Q41824593Tyrosine phosphorylation of membrane proteins mediates cellular invasion by transformed cells
Q40928111U.S. Environmental Protection Agency guidelines for carcinogen risk assessment: past and future
Q58561782Ultrasound Risk Assessment Combined with Molecular Markers of Galectin-3, c-MET, HBME-1 and CK19 for Diagnosis of Malignant and Benign Thyroid Nodules
Q28295203Uncoupling of Grb2 from the Met receptor in vivo reveals complex roles in muscle development
Q36734562Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth
Q26748581Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?
Q47680471Up-regulation of Vascular Endothelial Growth Factor Induced by Hepatocyte Growth Factor/Scatter Factor Stimulation in Human Glioma Cells
Q46757513Up-regulation of cyclin-E1 via proline-mTOR pathway is responsible for HGF-mediated G1/S progression in the primary culture of rat hepatocytes
Q55408333Upregulation of c-mesenchymal epithelial transition expression and RAS mutations are associated with late lung metastasis and poor prognosis in colorectal carcinoma.
Q89747820VEGF and bFGF induction by nitric oxide is associated with hyperbaric oxygen-induced angiogenesis and muscle regeneration
Q33850376Valproic acid, targets papillary thyroid cancer through inhibition of c-Met signalling pathway
Q40757756Vascular Origin of a Soluble Truncated Form of the Hepatocyte Growth Factor Receptor (c-met)
Q28282921White Matter Astrocytes Produce Hepatocyte Growth Factor Activator Inhibitor in Human Brain Tissues
Q39719310Wild-type but not mutant p53 activates the hepatocyte growth factor/scatter factor promoter
Q36544112Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells
Q24310364axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase
Q30451017c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas
Q28362076c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma
Q34342411c-Met Modulates RPE Migratory Response to Laser-Induced Retinal Injury
Q36441220c-Met Overexpression in Cervical Cancer, a Prognostic Factor and a Potential Molecular Therapeutic Target.
Q44810921c-Met activation in lung adenocarcinoma tissues: an immunohistochemical analysis.
Q91714272c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer
Q51158233c-Met and miRs in Cancer
Q37651008c-Met expression and activity in urogenital cancers - novel aspects of signal transduction and medical implications
Q95815293c-Met expression as an indicator of survival outcome in patients with oral tongue carcinoma
Q43195484c-Met inhibitors.
Q39735911c-Met is essential for wound healing in the skin
Q89786571c-Met is expressed by highly autoreactive encephalitogenic CD8+ cells
Q37998853c-Met: A potential therapeutic target for hepatocellular carcinoma
Q30303932c-Src, receptor tyrosine kinases, and human cancer
Q52122642c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma
Q48390858c-jun amino-terminal kinase and mitogen activated protein kinase 1/2 mediate hepatocyte growth factor-induced migration of brain endothelial cells
Q72694068c-met mRNA overexpression in human hepatocellular carcinoma
Q47349579c-met overexpression in supraglottic laryngeal squamous cell carcinoma and its relation to lymph node metastases
Q37290053cMET and phospho-cMET protein levels in breast cancers and survival outcomes
Q38450832c‐Met expression in tall cell variant papillary carcinoma of the thyroid
Q40659196p38 MAPK is involved in activin A- and hepatocyte growth factor-mediated expression of pro-endocrine gene neurogenin 3 in AR42J-B13 cells
Q36743308tpr-met oncogene product induces maturation-producing factor activation in Xenopus oocytes

Search more.